{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:32:21Z","timestamp":1792186341594,"version":"4.4.0"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00203-025-04695-4","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:38:33Z","timestamp":1768977513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Monkey pox (Mpox): pathogenesis, genetic shifts, vaccination strategies and clinical insights"],"prefix":"10.1007","volume":"208","author":[{"given":"Faiz","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash Kumar","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lal","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritam","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"4695_CR1","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","volume":"22","author":"H Adler","year":"2022","unstructured":"Adler H, Gould S, Hine P et al (2022) Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 22:1153\u20131162. https:\/\/doi.org\/10.1016\/S1473-3099(22)00228-6","journal-title":"Lancet Infect Dis"},{"key":"4695_CR2","unstructured":"Agnihothram S, Weina P, Food US et al (2024) Revision of JYNNEOS Letter of Authorization. U.S. Food and Drug Administration (FDA)"},{"key":"4695_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s00203-025-04367-3","volume":"207","author":"F Ahmad","year":"2025","unstructured":"Ahmad F, Sachdeva A, Sah BK et al (2025) A review of herbal therapeutics for the prevention and management of poxvirus infections. Arch Microbiol 207:186. https:\/\/doi.org\/10.1007\/s00203-025-04367-3","journal-title":"Arch Microbiol"},{"key":"4695_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41541-025-01174-1","volume":"10","author":"R Ahuja","year":"2025","unstructured":"Ahuja R, Vishwakarma P, Kumar V et al (2025) Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox. NPJ Vaccines 10:117. https:\/\/doi.org\/10.1038\/s41541-025-01174-1","journal-title":"NPJ Vaccines"},{"key":"4695_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2444","author":"F Akter","year":"2023","unstructured":"Akter F, Hasan TB, Alam F et al (2023) Effect of prior immunisation with smallpox vaccine for protection against human Mpox: a systematic review. Rev Med Virol. https:\/\/doi.org\/10.1002\/rmv.2444","journal-title":"Rev Med Virol"},{"key":"4695_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1360586","author":"E Alakunle","year":"2024","unstructured":"Alakunle E, Kolawole D, Diaz-C\u00e1nova D et al (2024) A comprehensive review of monkeypox virus and mpox characteristics. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2024.1360586","journal-title":"Front Cell Infect Microbiol"},{"key":"4695_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109108","volume":"243","author":"A Al-Musa","year":"2022","unstructured":"Al-Musa A, Chou J, LaBere B (2022) The resurgence of a neglected orthopoxvirus: immunologic and clinical aspects of monkeypox virus infections over the past six decades. Clin Immunol 243:109108. https:\/\/doi.org\/10.1016\/j.clim.2022.109108","journal-title":"Clin Immunol"},{"key":"4695_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1144325","author":"NM Alorfi","year":"2023","unstructured":"Alorfi NM, Alshehri FS, Haseeb A (2023) Characterization of interventional clinical trials for monkeypox; systematic review of ClinicalTrials.gov database. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2023.1144325"},{"key":"4695_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3390\/ph15091129","volume":"15","author":"HN Altayb","year":"2022","unstructured":"Altayb HN (2022) Fludarabine, a potential DNA-dependent RNA polymerase inhibitor, as a prospective drug against monkeypox virus: a computational approach. Pharmaceuticals 15:1129. https:\/\/doi.org\/10.3390\/ph15091129","journal-title":"Pharmaceuticals"},{"key":"4695_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jiph.2023.04.001","volume":"16","author":"F Amer","year":"2023","unstructured":"Amer F, Khalil HES, Elahmady M et al (2023) Mpox: risks and\u00a0approaches to prevention. J Infect Public Health 16:901\u2013910. https:\/\/doi.org\/10.1016\/j.jiph.2023.04.001","journal-title":"J Infect Public Health"},{"key":"4695_CR11","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200421","volume":"27","author":"A Antinori","year":"2022","unstructured":"Antinori A, Mazzotta V, Vita S et al (2022) Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Surveill 27:2200421. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.22.2200421","journal-title":"Euro Surveill"},{"key":"4695_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/pro.3729","volume":"29","author":"FC Azimi","year":"2020","unstructured":"Azimi FC, Lee JE (2020) Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. Protein Sci 29:391\u2013406. https:\/\/doi.org\/10.1002\/pro.3729","journal-title":"Protein Sci"},{"key":"4695_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101644","volume":"52","author":"JB Badenoch","year":"2022","unstructured":"Badenoch JB, Conti I, Rengasamy ER et al (2022) Neurological and psychiatric presentations associated with human monkeypox virus infection: a systematic review and meta-analysis. EClinicalMedicine 52:101644. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101644","journal-title":"EClinicalMedicine"},{"key":"4695_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1506687","author":"AH Barjasteh","year":"2025","unstructured":"Barjasteh AH, Latifi H, Sepehrinezhad A (2025) A bioinformatic analysis to systematically unveil shared pathways and molecular mechanisms underlying monkeypox and its predominant neurological manifestations. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2025.1506687","journal-title":"Front Cell Infect Microbiol"},{"key":"4695_CR15","unstructured":"BioSolutions E (2024) Emergent BioSolutions ACAM2000\u00ae, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions. Emergent BioSolutions"},{"key":"4695_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02862-22","author":"EM Bloch","year":"2022","unstructured":"Bloch EM, Sullivan DJ, Shoham S et al (2022) The potential role of passive antibody-based therapies as treatments for monkeypox. Mbio. https:\/\/doi.org\/10.1128\/mbio.02862-22","journal-title":"Mbio"},{"key":"4695_CR17","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","volume":"28","author":"GW Buchman","year":"2010","unstructured":"Buchman GW, Cohen ME, Xiao Y et al (2010) A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge. Vaccine 28:6627\u20136636. https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.030","journal-title":"Vaccine"},{"key":"4695_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L et al (2022) The changing epidemiology of human monkeypox-a potential threat? A systematic review. PLoS Negl Trop Dis 16:e0010141. https:\/\/doi.org\/10.1371\/journal.pntd.0010141","journal-title":"PLoS Negl Trop Dis"},{"key":"4695_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/zoonoticdis5010003","volume":"5","author":"EM Cambaza","year":"2025","unstructured":"Cambaza EM (2025) A review of the molecular understanding of the Mpox virus (MPXV): genomics, immune evasion, and therapeutic targets. Zoonotic Dis 5:3. https:\/\/doi.org\/10.3390\/zoonoticdis5010003","journal-title":"Zoonotic Dis"},{"key":"4695_CR20","unstructured":"CDC (2025) Interim clinical considerations for use of vaccine for Monkeypox prevention in the United States. https:\/\/www.cdc.gov\/monkeypox\/hcp\/vaccine-considerations\/vaccination-overview.html. Accessed 16 Nov 2025"},{"key":"4695_CR21","first-page":"642","volume":"52","author":"Centers for Disease Control and Prevention (CDC)","year":"2003","unstructured":"Centers for Disease Control and Prevention (CDC) (2003) Update: multistate outbreak of monkeypox\u2013Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 52:642\u2013646","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4695_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11262-025-02138-2","volume":"61","author":"C Chakraborty","year":"2025","unstructured":"Chakraborty C, Bhattacharya M, Das A, Abdelhameed AS (2025) Phylogenetic analyses of the spread of Clade I MPOX in African and non-African nations. Virus Genes 61:265\u2013276. https:\/\/doi.org\/10.1007\/s11262-025-02138-2","journal-title":"Virus Genes"},{"key":"4695_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2369193","author":"A Chen","year":"2024","unstructured":"Chen A, Fang N, Zhang Z et al (2024) Structural basis of the monkeypox virus mRNA cap N7 methyltransferase complex. Emerg Microbes Infect. https:\/\/doi.org\/10.1080\/22221751.2024.2369193","journal-title":"Emerg Microbes Infect"},{"key":"4695_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1295817","author":"A Choudhury","year":"2023","unstructured":"Choudhury A, Chandra A, Dawoud TM et al (2023) Immunoinformatics and reverse vaccinology approach in designing a novel highly immunogenic multivalent peptide-based vaccine against the human monkeypox virus. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2023.1295817","journal-title":"Front Mol Biosci"},{"key":"4695_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2278900","author":"Q Chu","year":"2023","unstructured":"Chu Q, Huang B, Li M et al (2023) Non-replicating vaccinia virus NTV as an effective next-generation smallpox and monkeypox vaccine: evidence from mouse and rhesus monkey models. Emerg Microbes Infect. https:\/\/doi.org\/10.1080\/22221751.2023.2278900","journal-title":"Emerg Microbes Infect"},{"key":"4695_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","volume":"72","author":"AF Dalton","year":"2023","unstructured":"Dalton AF, Diallo AO, Chard AN et al (2023) Estimated effectiveness of JYNNEOS vaccine in preventing Mpox: a multijurisdictional case-control study \u2013 United States, August 19, 2022\u2013March 31, 2023. MMWR Morb Mortal Wkly Rep 72:553\u2013558. https:\/\/doi.org\/10.15585\/mmwr.mm7220a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4695_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/23793406.2016.1171944","volume":"1","author":"A de Lambert Rouvroit","year":"2016","unstructured":"de Lambert Rouvroit A, Heegaard ED (2016) Total costs associated with replicating and non-replicating smallpox vaccines. Global Secur: Health, Sci Policy 1:3\u20139. https:\/\/doi.org\/10.1080\/23793406.2016.1171944","journal-title":"Global Secur: Health, Sci Policy"},{"key":"4695_CR28","doi-asserted-by":"publisher","unstructured":"Desingu PA, Nagarajan K (2022) Genomic regions insertion and deletion in Monkeypox virus causing multi-country outbreak-2022. https:\/\/doi.org\/10.1101\/2022.06.28.497936","DOI":"10.1101\/2022.06.28.497936"},{"key":"4695_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/vaccines10050709","volume":"10","author":"AA Deviatkin","year":"2022","unstructured":"Deviatkin AA, Simonov RA, Trutneva KA et al (2022) Universal flu mRNA vaccine: promises, prospects, and problems. Vaccines (Basel) 10:709. https:\/\/doi.org\/10.3390\/vaccines10050709","journal-title":"Vaccines (Basel)"},{"key":"4695_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","volume":"428","author":"PL Earl","year":"2004","unstructured":"Earl PL, Americo JL, Wyatt LS et al (2004) Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428:182\u2013185. https:\/\/doi.org\/10.1038\/nature02331","journal-title":"Nature"},{"key":"4695_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10896-5","volume":"25","author":"SO Ebede","year":"2025","unstructured":"Ebede SO, Orabueze IN, Maduakor UC et al (2025) Recurrent mpox: divergent virulent clades and the urgent need for strategic measures including novel vaccine development to sustain global health security. BMC Infect Dis 25:536. https:\/\/doi.org\/10.1186\/s12879-025-10896-5","journal-title":"BMC Infect Dis"},{"key":"4695_CR32","unstructured":"ECDC (2025) Mpox worldwide overview. In: European Centre for Disease Prevention and Control. https:\/\/www.ecdc.europa.eu\/en\/mpox-worldwide-overview. Accessed 16 Nov 2025"},{"key":"4695_CR33","unstructured":"Efridi W, Lappin SL. Poxviruses. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan\u2013. PMID: 32644385."},{"key":"4695_CR34","unstructured":"Fauci A (2002) Medicine (US) Board on Health Promotion I, Prevention and Development of Smallpox Vaccination: Efficacy, Availability, Duration of Immunity, and Timing, 1st edn. National Academies Press (US)"},{"key":"4695_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2022.105372","volume":"105","author":"D Forni","year":"2022","unstructured":"Forni D, Cagliani R, Molteni C et al (2022) Monkeypox virus: the changing facets of a zoonotic pathogen. Infect Genet Evol 105:105372. https:\/\/doi.org\/10.1016\/j.meegid.2022.105372","journal-title":"Infect Genet Evol"},{"key":"4695_CR36","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1016\/j.vaccine.2015.06.075","volume":"33","author":"SE Frey","year":"2015","unstructured":"Frey SE, Wald A, Edupuganti S et al (2015) Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-na\u00efve subjects. Vaccine 33:5225\u20135234. https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.075","journal-title":"Vaccine"},{"key":"4695_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1456060","author":"I Garcia-Atutxa","year":"2024","unstructured":"Garcia-Atutxa I, Mondragon-Teran P, Huerta-Saquero A, Villanueva-Flores F (2024) Advancements in monkeypox vaccines development: a critical review of emerging technologies. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1456060","journal-title":"Front Immunol"},{"key":"4695_CR38","unstructured":"GCP Networks (2025a) A Study to investigate the safety, tolerability, and immune response of a range of doses of mRNA-1769 compared with placebo in healthy participants from \u226518 years of age to <50 years of age. https:\/\/ichgcp.net\/clinical-trials-registry\/NCT05995275. Accessed 14 Dec 2025"},{"key":"4695_CR39","unstructured":"GCP Networks (2025b) A clinical study investigating the safety and immune responses after immunization with investigational Monkeypox vaccines. https:\/\/ichgcp.net\/clinical-trials-registry\/NCT05988203. Accessed 14 Dec 2025"},{"key":"4695_CR40","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2023.11","volume":"7","author":"M Ghaseminia","year":"2023","unstructured":"Ghaseminia M (2023) Preventing monkeypox outbreaks: focus on diagnosis, care, treatment, and vaccination. J Clin Transl Sci 7:e60. https:\/\/doi.org\/10.1017\/cts.2023.11","journal-title":"J Clin Transl Sci"},{"key":"4695_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.virs.2022.07.006","volume":"37","author":"Q Gong","year":"2022","unstructured":"Gong Q, Wang C, Chuai X, Chiu S (2022) Monkeypox virus: a re-emergent threat to humans. Virol Sin 37:477\u2013482. https:\/\/doi.org\/10.1016\/j.virs.2022.07.006","journal-title":"Virol Sin"},{"key":"4695_CR42","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/14760584.2024.2397006","volume":"23","author":"JD Grabenstein","year":"2024","unstructured":"Grabenstein JD, Hacker A (2024) Vaccines against mpox: MVA-BN and LC16m8. Expert Rev Vaccines 23:796\u2013811. https:\/\/doi.org\/10.1080\/14760584.2024.2397006","journal-title":"Expert Rev Vaccines"},{"key":"4695_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157335","volume":"11","author":"RN Greenberg","year":"2016","unstructured":"Greenberg RN, Hay CM, Stapleton JT et al (2016) A randomized, double-blind, placebo-controlled phase II trial investigating the safety and immunogenicity of modified vaccinia Ankara smallpox vaccine (MVA-BN\u00ae) in 56-80-year-old subjects. PLoS ONE 11:e0157335. https:\/\/doi.org\/10.1371\/journal.pone.0157335","journal-title":"PLoS ONE"},{"key":"4695_CR44","doi-asserted-by":"publisher","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","volume":"369","author":"B Greenwood","year":"2014","unstructured":"Greenwood B (2014) The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci 369:20130433. https:\/\/doi.org\/10.1098\/rstb.2013.0433","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"4695_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41541-022-00527-4","volume":"7","author":"MF Gruber","year":"2022","unstructured":"Gruber MF (2022) Current status of monkeypox vaccines. NPJ Vaccines 7:94. https:\/\/doi.org\/10.1038\/s41541-022-00527-4","journal-title":"NPJ Vaccines"},{"key":"4695_CR46","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nm1273","volume":"11","author":"E Hammarlund","year":"2005","unstructured":"Hammarlund E, Lewis MW, Carter SV et al (2005) Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med 11:1005\u20131011. https:\/\/doi.org\/10.1038\/nm1273","journal-title":"Nat Med"},{"key":"4695_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001769","volume":"20","author":"C Happi","year":"2022","unstructured":"Happi C, Adetifa I, Mbala P et al (2022) Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus. PLoS Biol 20:e3001769. https:\/\/doi.org\/10.1371\/journal.pbio.3001769","journal-title":"PLoS Biol"},{"key":"4695_CR48","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1080\/22221751.2022.2132882","volume":"11","author":"MM Hatmal","year":"2022","unstructured":"Hatmal MM, Al-Hatamleh MAI, Olaimat AN et al (2022) Comprehensive literature review of monkeypox. Emerg Microbes Infect 11:2600\u20132631. https:\/\/doi.org\/10.1080\/22221751.2022.2132882","journal-title":"Emerg Microbes Infect"},{"key":"4695_CR49","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1086\/498115","volume":"41","author":"GD Huhn","year":"2005","unstructured":"Huhn GD, Bauer AM, Yorita K et al (2005) Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis 41:1742\u20131751. https:\/\/doi.org\/10.1086\/498115","journal-title":"Clin Infect Dis"},{"key":"4695_CR50","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.vaccine.2024.01.064","volume":"42","author":"Y-H Hwang","year":"2024","unstructured":"Hwang Y-H, Byeon Y, Ahn SH et al (2024) Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces protective immune responses in mice. Vaccine 42:1283\u20131291. https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.064","journal-title":"Vaccine"},{"key":"4695_CR51","doi-asserted-by":"publisher","first-page":"29436","DOI":"10.1038\/s41598-024-79897-9","volume":"14","author":"S Imani","year":"2024","unstructured":"Imani S, Aminnezhad S, Alikarami M et al (2024) Exploration of drug repurposing for Mpox outbreaks targeting gene signatures and host-pathogen interactions. Sci Rep 14:29436. https:\/\/doi.org\/10.1038\/s41598-024-79897-9","journal-title":"Sci Rep"},{"key":"4695_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109772","volume":"76","author":"G Imre","year":"2020","unstructured":"Imre G (2020) Cell death signalling in virus infection. Cell Signal 76:109772. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109772","journal-title":"Cell Signal"},{"key":"4695_CR53","unstructured":"Isaacs SN, Mitj\u00e0 O (2025) Epidemiology, clinical manifestations, and diagnosis of Mpox (formerly monkeypox). UpToDate"},{"key":"4695_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.imj.2023.11.001","volume":"2","author":"MA Islam","year":"2023","unstructured":"Islam MA, Mumin J, Haque MM et al (2023) Monkeypox virus (MPXV): a brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions. Infect Med 2:262\u2013272. https:\/\/doi.org\/10.1016\/j.imj.2023.11.001","journal-title":"Infect Med"},{"key":"4695_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl4317","volume":"16","author":"C Jacob-Dolan","year":"2024","unstructured":"Jacob-Dolan C, Ty D, Hope D et al (2024) Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Sci Transl Med 16:eadl4317. https:\/\/doi.org\/10.1126\/scitranslmed.adl4317","journal-title":"Sci Transl Med"},{"key":"4695_CR56","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","volume":"156","author":"Z Jezek","year":"1987","unstructured":"Jezek Z, Szczeniowski M, Paluku KM, Mutombo M (1987) Human monkeypox: clinical features of 282 patients. J Infect Dis 156:293\u2013298. https:\/\/doi.org\/10.1093\/infdis\/156.2.293","journal-title":"J Infect Dis"},{"key":"4695_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12519-022-00624-3","volume":"19","author":"R-M Jiang","year":"2023","unstructured":"Jiang R-M, Zheng Y-J, Zhou L et al (2023) Diagnosis, treatment, and prevention of monkeypox in children: an experts\u2019 consensus statement. World J Pediatr 19:231\u2013242. https:\/\/doi.org\/10.1007\/s12519-022-00624-3","journal-title":"World J Pediatr"},{"key":"4695_CR58","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/14760584.2023.2198600","volume":"22","author":"BE Katamesh","year":"2023","unstructured":"Katamesh BE, Madany M, Labieb F, Abdelaal A (2023) Monkeypox pandemic containment: does the ACAM2000 vaccine play a role in the current outbreaks? Expert Rev Vaccines 22:366\u2013368. https:\/\/doi.org\/10.1080\/14760584.2023.2198600","journal-title":"Expert Rev Vaccines"},{"key":"4695_CR59","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/JS9.0000000000000123","volume":"109","author":"M Keikha","year":"2023","unstructured":"Keikha M, Zandhaghighi M, Shahraki Zahedani S (2023) Death-associated with human monkeypox outbreak 2022: the current perspectives \u2013 correspondence. Int J Surg 109:1806\u20131807. https:\/\/doi.org\/10.1097\/JS9.0000000000000123","journal-title":"Int J Surg"},{"key":"4695_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1586\/14760584.8.1.13","volume":"8","author":"JS Kennedy","year":"2009","unstructured":"Kennedy JS, Greenberg RN (2009) IMVAMUNE\u00ae: modified vaccinia Ankara strain as an attenuated smallpox vaccine. Expert Rev Vaccines 8:13\u201324. https:\/\/doi.org\/10.1586\/14760584.8.1.13","journal-title":"Expert Rev Vaccines"},{"key":"4695_CR61","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/infdis\/jir527","volume":"204","author":"JS Kennedy","year":"2011","unstructured":"Kennedy JS, Gurwith M, Dekker CL et al (2011) Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis 204:1395\u20131402. https:\/\/doi.org\/10.1093\/infdis\/jir527","journal-title":"J Infect Dis"},{"key":"4695_CR62","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","volume":"24","author":"J Kenner","year":"2006","unstructured":"Kenner J, Cameron F, Empig C et al (2006) LC16m8: an attenuated smallpox vaccine. Vaccine 24:7009\u20137022. https:\/\/doi.org\/10.1016\/j.vaccine.2006.03.087","journal-title":"Vaccine"},{"key":"4695_CR63","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12985-025-02982-6","volume":"22","author":"S Khan","year":"2025","unstructured":"Khan S, Ullah I, Rizwan M et al (2025) Immunoinformatics-based strategies for developing DNA and mRNA vaccines against monkeypox virus (MPXV). Virol J 22:377. https:\/\/doi.org\/10.1186\/s12985-025-02982-6","journal-title":"Virol J"},{"key":"4695_CR64","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1128\/JVI.00207-19","volume":"93","author":"P Kleinpeter","year":"2019","unstructured":"Kleinpeter P, Remy-Ziller C, Winter E et al (2019) By Binding CD80 and CD86, the Vaccinia Virus M2 protein blocks their interactions with both CD28 and CTLA4 and potentiates CD80 binding to PD-L1. J Virol 93:e207\u2013e219. https:\/\/doi.org\/10.1128\/JVI.00207-19","journal-title":"J Virol"},{"key":"4695_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.imj.2024.100105","volume":"3","author":"S Krishna","year":"2024","unstructured":"Krishna S, Kurrey C, Yadav M et al (2024) Insights into the emergence and evolution of monkeypox virus: historical perspectives, epidemiology, genetic diversity, transmission, and preventative measures. Infect Med 3:100105. https:\/\/doi.org\/10.1016\/j.imj.2024.100105","journal-title":"Infect Med"},{"key":"4695_CR66","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.22207\/JPAM.16.SPL1.17","volume":"16","author":"S Kulshrestha","year":"2022","unstructured":"Kulshrestha S, Rastogi A, Goel A (2022) Monkeypox virus: lessons learnt. J Pure Appl Microbiol 16:3072\u20133082. https:\/\/doi.org\/10.22207\/JPAM.16.SPL1.17","journal-title":"J Pure Appl Microbiol"},{"key":"4695_CR67","doi-asserted-by":"publisher","DOI":"10.37349\/ei.2025.1003203","author":"A Kumar","year":"2025","unstructured":"Kumar A, Ahmad F, Sah BK et al (2025) Advancements in viral vaccine development: from traditional to modern approaches. Explor Immunol. https:\/\/doi.org\/10.37349\/ei.2025.1003203","journal-title":"Explor Immunol"},{"key":"4695_CR68","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.1244040","volume":"341","author":"X-D Li","year":"2013","unstructured":"Li X-D, Wu J, Gao D et al (2013) Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341:1390\u20131394. https:\/\/doi.org\/10.1126\/science.1244040","journal-title":"Science"},{"key":"4695_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104424","volume":"87","author":"H Li","year":"2023","unstructured":"Li H, Huang Q-Z, Zhang H et al (2023) The land-scape of immune response to monkeypox virus. EBioMedicine 87:104424. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104424","journal-title":"EBioMedicine"},{"key":"4695_CR70","doi-asserted-by":"publisher","first-page":"7373","DOI":"10.1038\/s41467-025-61699-w","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Cheng L, Jiang L et al (2025) A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection. Nat Commun 16:7373. https:\/\/doi.org\/10.1038\/s41467-025-61699-w","journal-title":"Nat Commun"},{"key":"4695_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13090975","volume":"13","author":"M Lindemann","year":"2025","unstructured":"Lindemann M, Sammet S, Maischack F et al (2025) Long-term follow-up of T cell immunity against orthopoxviruses in people living with HIV after vaccination and natural monkeypox virus infection. Vaccine 13:975. https:\/\/doi.org\/10.3390\/vaccines13090975","journal-title":"Vaccine"},{"key":"4695_CR72","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2387442","author":"H Liu","year":"2024","unstructured":"Liu H, Wang W, Zhang Y et al (2024) Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity. Emerg Microbes Infect. https:\/\/doi.org\/10.1080\/22221751.2024.2387442","journal-title":"Emerg Microbes Infect"},{"key":"4695_CR73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bsheal.2022.09.004","volume":"4","author":"T Lu","year":"2022","unstructured":"Lu T, Wu Z, Jiang S et al (2022) The current emergence of monkeypox: the recurrence of another smallpox? Biosafety Health 4:369\u2013375. https:\/\/doi.org\/10.1016\/j.bsheal.2022.09.004","journal-title":"Biosafety Health"},{"key":"4695_CR74","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41392-023-01675-2","volume":"8","author":"J Lu","year":"2023","unstructured":"Lu J, Xing H, Wang C et al (2023) Mpox (formerly monkeypox): pathogenesis, prevention and treatment. Signal Transduct Target Ther 8:458. https:\/\/doi.org\/10.1038\/s41392-023-01675-2","journal-title":"Signal Transduct Target Ther"},{"key":"4695_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2023.102551","volume":"52","author":"N Luna","year":"2023","unstructured":"Luna N, Mu\u00f1oz M, Bonilla-Aldana DK et al (2023) Monkeypox virus (MPXV) genomics: a mutational and phylogenomic analyses of B.1 lineages. Travel Med Infect Dis 52:102551. https:\/\/doi.org\/10.1016\/j.tmaid.2023.102551","journal-title":"Travel Med Infect Dis"},{"key":"4695_CR76","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/life15071039","volume":"15","author":"Q Ma","year":"2025","unstructured":"Ma Q, Zhou X, Chen L et al (2025) Unveiling immune response mechanisms in Mpox infection through machine learning analysis of time series gene expression data. Life 15:1039. https:\/\/doi.org\/10.3390\/life15071039","journal-title":"Life"},{"key":"4695_CR77","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1128\/JVI.72.5.3524-3533.1998","volume":"72","author":"J Macen","year":"1998","unstructured":"Macen J, Takahashi A, Moon KB et al (1998) Activation of caspases in pig kidney cells infected with wild-type and CrmA\/SPI-2 mutants of cowpox and rabbitpox viruses. J Virol 72:3524\u20133533. https:\/\/doi.org\/10.1128\/JVI.72.5.3524-3533.1998","journal-title":"J Virol"},{"key":"4695_CR78","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41541-025-01300-z","volume":"10","author":"MSC Maciel","year":"2025","unstructured":"Maciel MSC, de Souza AA, Neri de Oliveira AL et al (2025) Pro-inflammatory cytokine profiles and neutralizing antibodies in JYNNEOS-vaccinated and mpox-diagnosed individuals. NPJ Vaccines 10:252. https:\/\/doi.org\/10.1038\/s41541-025-01300-z","journal-title":"NPJ Vaccines"},{"key":"4695_CR79","doi-asserted-by":"publisher","first-page":"88","DOI":"10.32607\/20758251-2017-9-2-88-93","volume":"9","author":"RA Maksyutov","year":"2017","unstructured":"Maksyutov RA, Yakubitskyi SN, Kolosova IV, Shchelkunov SN (2017) Comparing new-generation candidate vaccines against human orthopoxvirus infections. Acta Naturae 9:88\u201393","journal-title":"Acta Naturae"},{"key":"4695_CR80","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1091\/mbc.12.12.3875","volume":"12","author":"M Mallardo","year":"2001","unstructured":"Mallardo M, Schleich S, Krijnse Locker J (2001) Microtubule-dependent organization of vaccinia virus core\u2013derivd early mRNAs into distinct cytoplasmic structures. Mol Biol Cell 12:3875\u20133891. https:\/\/doi.org\/10.1091\/mbc.12.12.3875","journal-title":"Mol Biol Cell"},{"key":"4695_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20042963","volume":"20","author":"S Malone","year":"2023","unstructured":"Malone S, Mitra A, Onumah N et al (2023) Safety and efficacy of post-eradication smallpox vaccine as an mpox vaccine: a systematic review with meta-analysis. Int J Environ Res Public Health 20:2963. https:\/\/doi.org\/10.3390\/ijerph20042963","journal-title":"Int J Environ Res Public Health"},{"key":"4695_CR82","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/jir.2007.0113","volume":"28","author":"BA Mann","year":"2008","unstructured":"Mann BA, Huang JH, Li P et al (2008) Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. J Interferon Cytokine Res 28:367\u2013380. https:\/\/doi.org\/10.1089\/jir.2007.0113","journal-title":"J Interferon Cytokine Res"},{"key":"4695_CR83","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/bjd.21773","volume":"187","author":"CA Maronese","year":"2022","unstructured":"Maronese CA, Beretta A, Avallone G et al (2022) Clinical, dermoscopic and histopathological findings in localized human monkeypox: a case from northern Italy. Br J Dermatol 187:822\u2013823. https:\/\/doi.org\/10.1111\/bjd.21773","journal-title":"Br J Dermatol"},{"key":"4695_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126409","volume":"42","author":"LMK Mason","year":"2024","unstructured":"Mason LMK, Betancur E, Riera-Montes M et al (2024) MVA-BN vaccine effectiveness: a systematic review of real-world evidence in outbreak settings. Vaccine 42:126409. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126409","journal-title":"Vaccine"},{"key":"4695_CR85","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/jbc.M117.814541","volume":"293","author":"MH Matho","year":"2018","unstructured":"Matho MH, Schlossman A, Gilchuk IM et al (2018) Structure\u2013function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8. J Biol Chem 293:390\u2013401. https:\/\/doi.org\/10.1074\/jbc.M117.814541","journal-title":"J Biol Chem"},{"key":"4695_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102420","volume":"68","author":"V Mazzotta","year":"2024","unstructured":"Mazzotta V, Lepri AC, Matusali G et al (2024) Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study. EClinicalMedicine 68:102420. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102420","journal-title":"EClinicalMedicine"},{"key":"4695_CR174","doi-asserted-by":"publisher","unstructured":"McQuiston JH, Braden CR, Bowen MD, et al (2023) The CDC domestic mpox response - United States, 2022-2023. MMWR Morb Mortal Wkly Rep. 2023;72(20):547\u2013552. https:\/\/doi.org\/10.15585\/mmwr.mm7220a2}","DOI":"10.15585\/mmwr.mm7220a2"},{"key":"4695_CR87","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.cell.2018.06.053","volume":"174","author":"N Meade","year":"2018","unstructured":"Meade N, Furey C, Li H et al (2018) Poxviruses evade cytosolic sensing through disruption of an mTORC1-mTORC2 regulatory circuit. Cell 174:1143-1157.e17. https:\/\/doi.org\/10.1016\/j.cell.2018.06.053","journal-title":"Cell"},{"key":"4695_CR88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12889-023-17186-2","volume":"24","author":"A Mektebi","year":"2024","unstructured":"Mektebi A, Elsaid M, Yadav T et al (2024) Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis. BMC Public Health 24:4. https:\/\/doi.org\/10.1186\/s12889-023-17186-2","journal-title":"BMC Public Health"},{"key":"4695_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6010008","volume":"6","author":"S Melamed","year":"2018","unstructured":"Melamed S, Israely T, Paran N (2018) Challenges and achievements in prevention and treatment of smallpox. Vaccines (Basel) 6:8. https:\/\/doi.org\/10.3390\/vaccines6010008","journal-title":"Vaccines (Basel)"},{"key":"4695_CR90","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.4049\/jimmunol.1701364","volume":"200","author":"G M\u00e9ndez-Lagares","year":"2018","unstructured":"M\u00e9ndez-Lagares G, Lu D, Chen C et al (2018) Memory T cell proliferation before Hepatitis C virus therapy predicts antiviral immune responses and treatment success. J Immunol 200:1124\u20131132. https:\/\/doi.org\/10.4049\/jimmunol.1701364","journal-title":"J Immunol"},{"key":"4695_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111971","volume":"10","author":"SA Meo","year":"2022","unstructured":"Meo SA, Al-Masri AA, Klonoff DC et al (2022) Comparison of biological, pharmacological characteristics, indications, contraindications and adverse effects of JYNNEOS and ACAM2000 Monkeypox vaccines. Vaccines 10:1971. https:\/\/doi.org\/10.3390\/vaccines10111971","journal-title":"Vaccines"},{"key":"4695_CR92","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1099\/vir.0.2008\/004440-0","volume":"89","author":"CM Midgley","year":"2008","unstructured":"Midgley CM, Putz MM, Weber JN, Smith GL (2008) Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax. J Gen Virol 89:2992\u20132997. https:\/\/doi.org\/10.1099\/vir.0.2008\/004440-0","journal-title":"J Gen Virol"},{"key":"4695_CR93","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1107\/S2053230X22009128","volume":"78","author":"G Minasov","year":"2022","unstructured":"Minasov G, Inniss NL, Shuvalova L et al (2022) Structure of the Monkeypox virus profilin-like protein A42R reveals potential functional differences from cellular profilins. Acta Crystallogr F Struct Biol Commun 78:371\u2013377. https:\/\/doi.org\/10.1107\/S2053230X22009128","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"4695_CR94","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Alemany A, Marks M et al (2023) Mpox in people with advanced HIV infection: a global case series. Lancet 401:939\u2013949. https:\/\/doi.org\/10.1016\/S0140-6736(23)00273-8","journal-title":"Lancet"},{"key":"4695_CR95","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1097\/MS9.0000000000003064","volume":"87","author":"K Moghib","year":"2025","unstructured":"Moghib K, Asim A, Salomon I et al (2025) Monkeypox: an in-depth examination of epidemiology, pathophysiology, and global public health implications. Ann Med Surg 87:2093\u20132104. https:\/\/doi.org\/10.1097\/MS9.0000000000003064","journal-title":"Ann Med Surg"},{"key":"4695_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2023.102636","volume":"56","author":"S Mohanto","year":"2023","unstructured":"Mohanto S, Faiyazuddin M, Dilip Gholap A et al (2023) Addressing the resurgence of global monkeypox (Mpox) through advanced drug delivery platforms. Travel Med Infect Dis 56:102636. https:\/\/doi.org\/10.1016\/j.tmaid.2023.102636","journal-title":"Travel Med Infect Dis"},{"key":"4695_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300778","volume":"19","author":"AT Moin","year":"2024","unstructured":"Moin AT, Rani NA, Patil RB et al (2024) In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxviruses. PLoS ONE 19:e0300778. https:\/\/doi.org\/10.1371\/journal.pone.0300778","journal-title":"PLoS ONE"},{"key":"4695_CR98","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/978-0-387-95919-1_243","volume-title":"The Springer index of viruses","author":"B Moss","year":"2011","unstructured":"Moss B, Senkevich TG (2011) Orthopoxvirus. The Springer index of viruses. Springer, New York, NY, pp 1485\u20131494"},{"key":"4695_CR99","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01504-21","author":"EM Mucker","year":"2022","unstructured":"Mucker EM, Golden JW, Hammerbeck CD et al (2022) <article-title update=\"added\">A nucleic acid-based orthopoxvirus vaccine targeting the vaccinia virus L1, A27, B5, and A33 proteins protects rabbits against lethal rabbitpox virus aerosol challenge. J Virol. https:\/\/doi.org\/10.1128\/JVI.01504-21","journal-title":"J Virol"},{"key":"4695_CR100","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","volume":"187","author":"EM Mucker","year":"2024","unstructured":"Mucker EM, Freyn AW, Bixler SL et al (2024) Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates. Cell 187:5540-5553.e10. https:\/\/doi.org\/10.1016\/j.cell.2024.08.043","journal-title":"Cell"},{"key":"4695_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28206","volume":"95","author":"AG Mukherjee","year":"2023","unstructured":"Mukherjee AG, Wanjari UR, Kannampuzha S et al (2023) Expression of concern: the pathophysiological and immunological background of the monkeypox virus infection: an update. J Med Virol 95:e28206. https:\/\/doi.org\/10.1002\/jmv.28206","journal-title":"J Med Virol"},{"key":"4695_CR102","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4161\/viru.23134","volume":"4","author":"M Munir","year":"2013","unstructured":"Munir M, Berg M (2013) The multiple faces of proteinkinase R in antiviral defense. Virulence 4:85\u201389. https:\/\/doi.org\/10.4161\/viru.23134","journal-title":"Virulence"},{"key":"4695_CR103","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.22207\/JPAM.16.SPL1.22","volume":"16","author":"N Nainwal","year":"2022","unstructured":"Nainwal N, Jakhmola V (2022) Candidate vaccines and therapeutics against monkeypox infection. J Pure Appl Microbiol 16:3096\u20133105. https:\/\/doi.org\/10.22207\/JPAM.16.SPL1.22","journal-title":"J Pure Appl Microbiol"},{"key":"4695_CR104","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.4254\/wjh.v7.i25.2590","volume":"7","author":"K Nakatsuka","year":"2015","unstructured":"Nakatsuka K (2015) Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1\/2 cell balance into T helper 1 dominance. World J Hepatol 7:2590. https:\/\/doi.org\/10.4254\/wjh.v7.i25.2590","journal-title":"World J Hepatol"},{"key":"4695_CR105","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/DDDT.S3687","volume":"25","author":"A Nalca","year":"2010","unstructured":"Nalca A, Zumbrun EE (2010) ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. Drug des Devel Ther 25:71\u201379. https:\/\/doi.org\/10.2147\/DDDT.S3687","journal-title":"Drug des Devel Ther"},{"key":"4695_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11091410","volume":"11","author":"L Nave","year":"2023","unstructured":"Nave L, Margalit I, Tau N et al (2023) Immunogenicity and safety of modified vaccinia Ankara (MVA) vaccine-a systematic review and meta-analysis of randomized controlled trials. Vaccines 11:1410. https:\/\/doi.org\/10.3390\/vaccines11091410","journal-title":"Vaccines"},{"key":"4695_CR107","unstructured":"NIH (2024) Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC. https:\/\/clinicaltrials.gov\/study\/NCT05734508. Accessed 14 Dec 2025"},{"key":"4695_CR108","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1042\/BC20040058","volume":"97","author":"RR Novoa","year":"2005","unstructured":"Novoa RR, Calderita G, Arranz R et al (2005) Virus factories: associations of cell organelles for viral replication and morphogenesis. Biol Cell 97:147\u2013172. https:\/\/doi.org\/10.1042\/BC20040058","journal-title":"Biol Cell"},{"key":"4695_CR109","doi-asserted-by":"publisher","first-page":"1334238","DOI":"10.3389\/fpubh.2023.1334238","volume":"11","author":"SC Ogunleye","year":"2024","unstructured":"Ogunleye SC, Akinsulie OC, Aborode AT et al (2024) The re-emergence and transmission of Monkeypox virus in Nigeria: the role of one health. Front Public Health 11:1334238. https:\/\/doi.org\/10.3389\/fpubh.2023.1334238","journal-title":"Front Public Health"},{"key":"4695_CR110","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1080\/17435889.2024.2419815","volume":"19","author":"Y Omidi","year":"2024","unstructured":"Omidi Y, Pourseif MM, Ansari RA, Barar J (2024) Design and development of mRNA and self-amplifying mRNA vaccine nanoformulations. Nanomedicine 19:2699\u20132725. https:\/\/doi.org\/10.1080\/17435889.2024.2419815","journal-title":"Nanomedicine"},{"key":"4695_CR111","doi-asserted-by":"publisher","DOI":"10.37349\/ei.2025.1003213","author":"S Pal","year":"2025","unstructured":"Pal S, Samanta S, Bhowmick B, Bera K (2025) Understanding mpox pathogenesis: therapeutic potential of marine-derived drugs. Explor Immunol. https:\/\/doi.org\/10.37349\/ei.2025.1003213","journal-title":"Explor Immunol"},{"key":"4695_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105179","volume":"195","author":"S Parker","year":"2021","unstructured":"Parker S, D\u2019Angelo J, Buller RM et al (2021) A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge. Antiviral Res 195:105179. https:\/\/doi.org\/10.1016\/j.antiviral.2021.105179","journal-title":"Antiviral Res"},{"key":"4695_CR113","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.vaccine.2006.10.047","volume":"25","author":"J Parrino","year":"2007","unstructured":"Parrino J, McCurdy LH, Larkin BD et al (2007) Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-na\u00efve and vaccinia-immune individuals. Vaccine 25:1513\u20131525. https:\/\/doi.org\/10.1016\/j.vaccine.2006.10.047","journal-title":"Vaccine"},{"key":"4695_CR114","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.ade6360","volume":"379","author":"Q Peng","year":"2023","unstructured":"Peng Q, Xie Y, Kuai L et al (2023) Structure of monkeypox virus DNA polymerase holoenzyme. Science 379:100\u2013105. https:\/\/doi.org\/10.1126\/science.ade6360","journal-title":"Science"},{"key":"4695_CR115","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1016\/S2468-2667(23)00061-0","volume":"8","author":"G Persad","year":"2023","unstructured":"Persad G, Leland RJ, Ottersen T et al (2023) Fair domestic allocation of monkeypox virus countermeasures. Lancet Public Health 8:e378\u2013e382. https:\/\/doi.org\/10.1016\/S2468-2667(23)00061-0","journal-title":"Lancet Public Health"},{"key":"4695_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003649","volume":"9","author":"NE Peters","year":"2013","unstructured":"Peters NE, Ferguson BJ, Mazzon M et al (2013) A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog 9:e1003649. https:\/\/doi.org\/10.1371\/journal.ppat.1003649","journal-title":"PLoS Pathog"},{"key":"4695_CR117","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ijid.2022.06.047","volume":"122","author":"E Petersen","year":"2022","unstructured":"Petersen E, Zumla A, Hui D et al (2022) Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3. Int J Infect Dis 122:569\u2013571. https:\/\/doi.org\/10.1016\/j.ijid.2022.06.047","journal-title":"Int J Infect Dis"},{"key":"4695_CR118","unstructured":"Pharmaceuticals, (PMDA) MDA, KM Biologics Co. Ltd (2024) Freeze-dried Smallpox Vaccine Prepared in Cell Culture LC16 \u201cKMB\u201d (Revised 2024). Pharmaceuticals and Medical Devices Agency (PMDA)"},{"key":"4695_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004904","volume":"11","author":"DJ Pickup","year":"2015","unstructured":"Pickup DJ (2015) Extracellular virions: the advance guard of poxvirus infections. PLoS Pathog 11:e1004904. https:\/\/doi.org\/10.1371\/journal.ppat.1004904","journal-title":"PLoS Pathog"},{"key":"4695_CR120","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","volume":"381","author":"PR Pittman","year":"2019","unstructured":"Pittman PR, Hahn M, Lee HS et al (2019) Phase 3 efficacy trial of modified vaccinia Ankara as a vaccine against smallpox. N Engl J Med 381:1897\u20131908. https:\/\/doi.org\/10.1056\/NEJMoa1817307","journal-title":"N Engl J Med"},{"key":"4695_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103341","volume":"27","author":"MM Pourseif","year":"2022","unstructured":"Pourseif MM, Masoudi-Sobhanzadeh Y, Azari E et al (2022) Self-amplifying mRNA vaccines: mode of action, design, development and optimization. Drug Discov Today 27:103341. https:\/\/doi.org\/10.1016\/j.drudis.2022.103341","journal-title":"Drug Discov Today"},{"key":"4695_CR122","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","volume":"71","author":"AK Rao","year":"2022","unstructured":"Rao AK, Petersen BW, Whitehill F et al (2022) Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep 71:734\u2013742. https:\/\/doi.org\/10.15585\/mmwr.mm7122e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4695_CR123","doi-asserted-by":"publisher","unstructured":"Rastogi A, Kumar M (2024) Current status of vaccine development for Monkeypox virus. pp 289\u2013300. } } Rastogi A, Kumar M. Current Status of Vaccine Development for Monkeypox Virus. Adv Exp Med Biol. 2024;1451:289-300. https:\/\/doi.org\/10.1007\/978-3-031-57165-7_18}","DOI":"10.1007\/978-3-031-57165-7_18"},{"key":"4695_CR124","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1128\/JVI.00011-17","volume":"91","author":"S Realegeno","year":"2017","unstructured":"Realegeno S, Puschnik AS, Kumar A et al (2017) Monkeypox virus host factor screen using haploid cells identifies essential role of GARP complex in extracellular virus formation. J Virol 91:e11-17. https:\/\/doi.org\/10.1128\/JVI.00011-17","journal-title":"J Virol"},{"key":"4695_CR125","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMoa032299","volume":"350","author":"KD Reed","year":"2004","unstructured":"Reed KD, Melski JW, Graham MB et al (2004) The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 350:342\u2013350. https:\/\/doi.org\/10.1056\/NEJMoa032299","journal-title":"N Engl J Med"},{"key":"4695_CR126","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.medcle.2023.01.005","volume":"160","author":"J Reina","year":"2023","unstructured":"Reina J, Iglesias C (2023) Vaccines against monkeypox. Medicina Cl\u00ednica (English Edition) 160:305\u2013309. https:\/\/doi.org\/10.1016\/j.medcle.2023.01.005","journal-title":"Medicina Cl\u00ednica (English Edition)"},{"key":"4695_CR127","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1073\/pnas.1005769107","volume":"107","author":"AW Rimoin","year":"2010","unstructured":"Rimoin AW, Mulembakani PM, Johnston SC et al (2010) Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci USA 107:16262\u201316267. https:\/\/doi.org\/10.1073\/pnas.1005769107","journal-title":"Proc Natl Acad Sci USA"},{"key":"4695_CR128","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","volume":"82","author":"JG Rizk","year":"2022","unstructured":"Rizk JG, Lippi G, Henry BM et al (2022) Prevention and treatment of monkeypox. Drugs 82:957\u2013963. https:\/\/doi.org\/10.1007\/s40265-022-01742-y","journal-title":"Drugs"},{"key":"4695_CR129","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1016\/j.vaccine.2023.04.010","volume":"41","author":"RL Roper","year":"2023","unstructured":"Roper RL, Garzino-Demo A, Del Rio C et al (2023) Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies. Vaccine 41:3171\u20133177. https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.010","journal-title":"Vaccine"},{"key":"4695_CR130","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","volume":"19","author":"AT Russo","year":"2021","unstructured":"Russo AT, Grosenbach DW, Chinsangaram J et al (2021) An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther 19:331\u2013344. https:\/\/doi.org\/10.1080\/14787210.2020.1819791","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4695_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106156","volume":"180","author":"MJ Saadh","year":"2023","unstructured":"Saadh MJ, Ghadimkhani T, Soltani N et al (2023) Progress and prospects on vaccine development against monkeypox infection. Microb Pathog 180:106156. https:\/\/doi.org\/10.1016\/j.micpath.2023.106156","journal-title":"Microb Pathog"},{"key":"4695_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1414224","author":"K Sagdat","year":"2024","unstructured":"Sagdat K, Batyrkhan A, Kanayeva D (2024) Exploring monkeypox virus proteins and rapid detection techniques. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2024.1414224","journal-title":"Front Cell Infect Microbiol"},{"key":"4695_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109364","volume":"113","author":"A Saghazadeh","year":"2022","unstructured":"Saghazadeh A, Rezaei N (2022) Poxviruses and the immune system: implications for monkeypox virus. Int Immunopharmacol 113:109364. https:\/\/doi.org\/10.1016\/j.intimp.2022.109364","journal-title":"Int Immunopharmacol"},{"key":"4695_CR134","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/JS9.0000000000000142","volume":"109","author":"R Sah","year":"2023","unstructured":"Sah R, Paul D, Mohanty A et al (2023) Monkeypox (Mpox) vaccines and their side effects: the other side of the coin. Int J Surg 109:215\u2013217. https:\/\/doi.org\/10.1097\/JS9.0000000000000142","journal-title":"Int J Surg"},{"key":"4695_CR135","doi-asserted-by":"publisher","first-page":"992","DOI":"10.15585\/mmwr.mm7236a4","volume":"72","author":"S Schildhauer","year":"2023","unstructured":"Schildhauer S, Saadeh K, Vance J et al (2023) Reduced odds of Mpox-associated hospitalization among persons who received JYNNEOS vaccine - California, May 2022-May 2023. MMWR Morb Mortal Wkly Rep 72:992\u2013996. https:\/\/doi.org\/10.15585\/mmwr.mm7236a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4695_CR136","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28251","author":"M Shafaati","year":"2023","unstructured":"Shafaati M, Zandi M (2023) Human monkeypox (hMPXV) re-emergence: host immunity status and current vaccines landscape. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.28251","journal-title":"J Med Virol"},{"key":"4695_CR137","doi-asserted-by":"publisher","DOI":"10.1177\/25151355251314339","author":"M Shafaati","year":"2025","unstructured":"Shafaati M, Forghani S, Shahsavand Davoudi A et al (2025) Current advances and challenges in mpox vaccine development: a global landscape. Ther Adv Vaccines Immunother. https:\/\/doi.org\/10.1177\/25151355251314339","journal-title":"Ther Adv Vaccines Immunother"},{"key":"4695_CR138","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29166","author":"W Shang","year":"2023","unstructured":"Shang W, Cao G, Wu Y et al (2023) Spatiotemporal cluster of mpox in men who have sex with men: a modeling study in 83 countries. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.29166","journal-title":"J Med Virol"},{"key":"4695_CR139","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","volume":"509","author":"SN Shchelkunov","year":"2001","unstructured":"Shchelkunov SN, Totmenin AV, Babkin IV et al (2001) Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett 509:66\u201370. https:\/\/doi.org\/10.1016\/S0014-5793(01)03144-1","journal-title":"FEBS Lett"},{"key":"4695_CR140","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/viro.2002.1446","volume":"297","author":"SN Shchelkunov","year":"2002","unstructured":"Shchelkunov SN, Totmenin AV, Safronov PF et al (2002) Analysis of the monkeypox virus genome. Virology 297:172\u2013194. https:\/\/doi.org\/10.1006\/viro.2002.1446","journal-title":"Virology"},{"key":"4695_CR141","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/v15010103","volume":"15","author":"GA Shchelkunova","year":"2022","unstructured":"Shchelkunova GA, Shchelkunov SN (2022) Smallpox, monkeypox and other human orthopoxvirus infections. Viruses 15:103. https:\/\/doi.org\/10.3390\/v15010103","journal-title":"Viruses"},{"key":"4695_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2024.101487","volume":"62","author":"P Singh","year":"2024","unstructured":"Singh P, Sridhar SB, Shareef J et al (2024) The resurgence of monkeypox: epidemiology, clinical features, and public health implications in the post-smallpox eradication era. New Microbes New Infect 62:101487. https:\/\/doi.org\/10.1016\/j.nmni.2024.101487","journal-title":"New Microbes New Infect"},{"key":"4695_CR143","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1186\/s12879-022-07900-7","volume":"22","author":"S Sukhdeo","year":"2022","unstructured":"Sukhdeo S, Mishra S, Walmsley S (2022) Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease. BMC Infect Dis 22:928. https:\/\/doi.org\/10.1186\/s12879-022-07900-7","journal-title":"BMC Infect Dis"},{"key":"4695_CR144","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0092-8674(95)90076-4","volume":"81","author":"JA Symons","year":"1995","unstructured":"Symons JA, Alcam\u00ed A, Smith GL (1995) Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity. Cell 81:551\u2013560. https:\/\/doi.org\/10.1016\/0092-8674(95)90076-4","journal-title":"Cell"},{"key":"4695_CR145","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.4161\/hv.24319","volume":"9","author":"DM Tack","year":"2013","unstructured":"Tack DM, Karem KL, Montgomery JR et al (2013) Unintentional transfer of vaccinia virus associated with smallpox vaccines. Hum Vaccin Immunother 9:1489\u20131496. https:\/\/doi.org\/10.4161\/hv.24319","journal-title":"Hum Vaccin Immunother"},{"key":"4695_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1112816","author":"C Tan","year":"2023","unstructured":"Tan C, Zhu F, Pan P et al (2023) Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1112816","journal-title":"Front Immunol"},{"key":"4695_CR147","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s11010-022-04657-0","volume":"478","author":"M Thakur","year":"2023","unstructured":"Thakur M, Das P, Sobti RC, Kaur T (2023) Human monkeypox: epidemiology, transmission, pathogenesis, immunology, diagnosis and therapeutics. Mol Cell Biochem 478:2097\u20132110. https:\/\/doi.org\/10.1007\/s11010-022-04657-0","journal-title":"Mol Cell Biochem"},{"key":"4695_CR148","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/infdis\/jiad245","volume":"229","author":"CC Traut","year":"2024","unstructured":"Traut CC, Jones JL, Sanders RA et al (2024) Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients. J Infect Dis 229:54\u201358. https:\/\/doi.org\/10.1093\/infdis\/jiad245","journal-title":"J Infect Dis"},{"key":"4695_CR149","doi-asserted-by":"publisher","first-page":"1160984","DOI":"10.3389\/fmicb.2023.1160984","volume":"14","author":"M Ullah","year":"2023","unstructured":"Ullah M, Li Y, Munib K, Zhang Z (2023) Epidemiology, host range, and associated risk factors of monkeypox: an emerging global public health threat. Front Microbiol 14:1160984. https:\/\/doi.org\/10.3389\/fmicb.2023.1160984","journal-title":"Front Microbiol"},{"key":"4695_CR150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002247","volume":"7","author":"L Unterholzner","year":"2011","unstructured":"Unterholzner L, Sumner RP, Baran M et al (2011) Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7. PLoS Pathog 7:e1002247. https:\/\/doi.org\/10.1371\/journal.ppat.1002247","journal-title":"PLoS Pathog"},{"key":"4695_CR151","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1038\/s41591-024-03130-3","volume":"30","author":"EH Vakaniaki","year":"2024","unstructured":"Vakaniaki EH, Kacita C, Kinganda-Lusamaki E et al (2024) Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo. Nat Med 30:2791\u20132795. https:\/\/doi.org\/10.1038\/s41591-024-03130-3","journal-title":"Nat Med"},{"key":"4695_CR152","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","volume":"30","author":"C Verheust","year":"2012","unstructured":"Verheust C, Goossens M, Pauwels K, Breyer D (2012) Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination. Vaccine 30:2623\u20132632. https:\/\/doi.org\/10.1016\/j.vaccine.2012.02.016","journal-title":"Vaccine"},{"key":"4695_CR153","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200422","author":"R Vivancos","year":"2022","unstructured":"Vivancos R, Anderson C, Blomquist P et al (2022) Community transmission of monkeypox in the United Kingdom, April to May 2022. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.22.2200422","journal-title":"Euro Surveill"},{"key":"4695_CR154","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/14760584.2016.1175305","volume":"15","author":"EA Voigt","year":"2016","unstructured":"Voigt EA, Kennedy RB, Poland GA (2016) Defending against smallpox: a focus on vaccines. Expert Rev Vaccines 15:1197\u20131211. https:\/\/doi.org\/10.1080\/14760584.2016.1175305","journal-title":"Expert Rev Vaccines"},{"key":"4695_CR155","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","volume":"46","author":"P von Magnus","year":"1959","unstructured":"von Magnus P, Andersen EK, Petersen KB, Birch-Andersen A (1959) A pox-like disease in cynomolgus monkeys. Acta Pathol Microbiol Scand 46:156\u2013176. https:\/\/doi.org\/10.1111\/j.1699-0463.1959.tb00328.x","journal-title":"Acta Pathol Microbiol Scand"},{"key":"4695_CR156","doi-asserted-by":"publisher","first-page":"118","DOI":"10.46234\/ccdcw2024.025","volume":"6","author":"X Wang","year":"2024","unstructured":"Wang X, Gu Z, Sheng S et al (2024) The current state and progress of Mpox vaccine research. China CDC Wkly 6:118\u2013125. https:\/\/doi.org\/10.46234\/ccdcw2024.025","journal-title":"China CDC Wkly"},{"key":"4695_CR157","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1086\/498155","volume":"41","author":"RA Weinstein","year":"2005","unstructured":"Weinstein RA, Nalca A, Rimoin AW et al (2005) Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis 41:1765\u20131771. https:\/\/doi.org\/10.1086\/498155","journal-title":"Clin Infect Dis"},{"key":"4695_CR158","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","volume":"10","author":"R Wittek","year":"2006","unstructured":"Wittek R (2006) Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. Int J Infect Dis 10:193\u2013201. https:\/\/doi.org\/10.1016\/j.ijid.2005.12.001","journal-title":"Int J Infect Dis"},{"key":"4695_CR159","unstructured":"World Health Organization (2025) Global Mpox Trends. https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/#sec-global. Accessed 14 Dec 2025"},{"key":"4695_CR160","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taad048","author":"M Xu","year":"2023","unstructured":"Xu M, Liu C, Du Z et al (2023) Real-world effectiveness of monkeypox vaccines: a systematic review. J Travel Med. https:\/\/doi.org\/10.1093\/jtm\/taad048","journal-title":"J Travel Med"},{"key":"4695_CR161","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41541-025-01193-y","volume":"10","author":"F Xu","year":"2025","unstructured":"Xu F, Huang Y, Hou Y et al (2025) A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques. NPJ Vaccines 10:134. https:\/\/doi.org\/10.1038\/s41541-025-01193-y","journal-title":"NPJ Vaccines"},{"key":"4695_CR162","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.virs.2022.10.004","volume":"38","author":"L Yang","year":"2023","unstructured":"Yang L, Chen Y, Li S et al (2023) Immunization of mice with vaccinia virus Tiantan strain yields antibodies cross-reactive with protective antigens of monkeypox virus. Virol Sin 38:162\u2013164. https:\/\/doi.org\/10.1016\/j.virs.2022.10.004","journal-title":"Virol Sin"},{"key":"4695_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114269","volume":"43","author":"T Ye","year":"2024","unstructured":"Ye T, Zhou J, Guo C et al (2024) Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus. Cell Rep 43:114269. https:\/\/doi.org\/10.1016\/j.celrep.2024.114269","journal-title":"Cell Rep"},{"key":"4695_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2024.100185","volume":"3","author":"X-M Yi","year":"2024","unstructured":"Yi X-M, Lei Y-L, Li M et al (2024) The monkeypox virus-host interplays. Cell Insight 3:100185. https:\/\/doi.org\/10.1016\/j.cellin.2024.100185","journal-title":"Cell Insight"},{"key":"4695_CR165","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00576-24","author":"B Young","year":"2024","unstructured":"Young B, Seifert SN, Lawson C, Koehler H (2024) Exploring the genomic basis of Mpox virus-host transmission and pathogenesis. mSphere. https:\/\/doi.org\/10.1128\/msphere.00576-24","journal-title":"mSphere"},{"key":"4695_CR166","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.tips.2025.08.009","volume":"46","author":"X-F Yu","year":"2025","unstructured":"Yu X-F, Wang S, Ye R, Wei W (2025) Viral evasion of cGAS-STING pathway: opportunities for intervention. Trends Pharmacol Sci 46:989\u20131003. https:\/\/doi.org\/10.1016\/j.tips.2025.08.009","journal-title":"Trends Pharmacol Sci"},{"key":"4695_CR167","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","volume":"29","author":"LM Zaeck","year":"2023","unstructured":"Zaeck LM, Lamers MM, Verstrepen BE et al (2023) Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nat Med 29:270\u2013278. https:\/\/doi.org\/10.1038\/s41591-022-02090-w","journal-title":"Nat Med"},{"key":"4695_CR168","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1007\/s00018-011-0797-0","volume":"68","author":"B Zafirova","year":"2011","unstructured":"Zafirova B, Wensveen FM, Gulin M, Poli\u0107 B (2011) Regulation of immune cell function and differentiation by the NKG2D receptor. Cell Mol Life Sci 68:3519\u20133529. https:\/\/doi.org\/10.1007\/s00018-011-0797-0","journal-title":"Cell Mol Life Sci"},{"key":"4695_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1106247","author":"M Zandi","year":"2023","unstructured":"Zandi M, Shafaati M, Hosseini F (2023) Mechanisms of immune evasion of monkeypox virus. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1106247","journal-title":"Front Microbiol"},{"key":"4695_CR170","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1074\/jbc.M109.078113","volume":"285","author":"D Zhai","year":"2010","unstructured":"Zhai D, Yu E, Jin C et al (2010) Vaccinia virus protein F1L is a caspase-9 inhibitor. J Biol Chem 285:5569\u20135580. https:\/\/doi.org\/10.1074\/jbc.M109.078113","journal-title":"J Biol Chem"},{"issue":"2","key":"4695_CR171","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3967\/BES2024.121","volume":"38","author":"Y Zhai","year":"2025","unstructured":"Zhai Y, Han Y, Wang W et al (2025) Advancements in Mpox vaccine development: a comprehensive review of global progress and recent data. Biomed Environ Sci 38(2):248\u2013254. https:\/\/doi.org\/10.3967\/BES2024.121","journal-title":"Biomed Environ Sci"},{"key":"4695_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-024-00680-1","volume":"10","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Yang M et al (2024) Structural and functional insights into the helicase protein E5 of Mpox virus. Cell Discov 10:67. https:\/\/doi.org\/10.1038\/s41421-024-00680-1","journal-title":"Cell Discov"},{"key":"4695_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.imj.2025.100165","volume":"4","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Sun Q, Xu Y et al (2025) Novel drug targets for monkeypox: from viral to host proteins. Infect Med 4:100165. https:\/\/doi.org\/10.1016\/j.imj.2025.100165","journal-title":"Infect Med"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04695-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04695-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04695-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:59:30Z","timestamp":1773316770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04695-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":174,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4695"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04695-4","relation":{"references":[{"id-type":"doi","id":"10.3389\/fpubh.2023.1144325","asserted-by":"subject"}]},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"151"}}